Great Point Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-311,217	Closed	-$8.03M	–	31
2021 Q1	$8.03M	Sell	311,217 -409,285	-57%	-$18M	1.66%	21
2020 Q4	$38.5M	Sell	720,502 -1,201,061	-63%	-$59.6M	6.35%	4
2020 Q3	$79.3M	Buy	1,921,563 +116,570	+6%	+$5.03M	7.17%	3
2020 Q2	$87.5M	Sell	1,804,993 -190,754	-10%	-$9.16M	7.03%	4
2020 Q1	$84.3M	Buy	1,995,747 +745,747	+60%	+$30.7M	9.52%	1
2019 Q4	$53.5M	Sell	1,250,000 -940,742	-43%	-$40.9M	5.14%	10
2019 Q3	$78.8M	Buy	2,190,742 +690,742	+46%	+$20.9M	8.34%	3
2019 Q2	$40.1M	Sell	1,500,000 -500,000	-25%	-$12.8M	4.87%	9
2019 Q1	$53.7M	Sell	2,000,000 -752,256	-27%	-$17.6M	5.95%	5
2018 Q4	$44.5M	Buy	2,752,256 +1,556,158	+130%	+$30.2M	6.18%	5
2018 Q3	$24.8M	Sell	1,196,098 -803,902	-40%	-$12.6M	3.9%	13
2018 Q2	$30.5M	Buy	+2,000,000	New	+$35.7M	4.82%	9
2017 Q1	–	Sell	-270,000	Closed	-$7.79M	–	38
2016 Q4	$7.79M	Buy	+270,000	New	+$7.14M	1.72%	20
2016 Q2	–	Sell	-100,000	Closed	-$2.8M	–	40
2016 Q1	$2.8M	Buy	+100,000	New	+$2.18M	1.07%	25